Loading organizations...
§ Private Profile · Chausseestraße 8, Berlin, Berlin, 10115, Germany
Qunomedical is a technology company.
Qunomedical operates a digital health platform that facilitates global access to high-quality and affordable medical treatments. The platform serves as a personalized support service, guiding individuals through the complexities of finding suitable care options both domestically and internationally. It leverages technology to streamline the patient journey from initial inquiry to treatment, focusing on transparency and patient-centric support.
The company was founded in 2015 by Dr. Sophie Chung and Gero Graf. Their insight stemmed from recognizing a significant global disparity in healthcare accessibility and cost, coupled with a lack of trusted resources for individuals seeking treatment beyond their immediate geographical reach. This led to the creation of a system designed to empower patients with choices and reliable information.
The platform primarily serves patients worldwide who are seeking diverse medical procedures and require assistance navigating the international healthcare landscape. Qunomedical's overarching vision is to democratize healthcare by making it universally affordable and accessible, ensuring that patients can always find the best possible treatment tailored to their needs, regardless of location or economic circumstance.
Qunomedical has raised $14.0M across 3 funding rounds.
Qunomedical has raised $14.0M in total across 3 funding rounds.
Qunomedical is a Berlin-based digital health platform founded in 2015 or 2016 that connects patients worldwide with vetted clinics and physicians across over 35 countries, offering treatments in areas like dentistry, plastic surgery, ophthalmology, orthopedics, reproductive medicine, and weight loss surgery.[1][3][4][5] It operates a dual model: a B2C platform for patients seeking affordable, high-quality care with personalized support, and Qunosuite, a B2B CRM solution for healthcare providers to streamline patient acquisition, communication, and management.[1][2][4][6] Serving over 6,500 to 10,000 patients monthly from a team of around 50 employees, Qunomedical emphasizes patient-first experiences, transparency, and efficiency, with recent momentum including a €10m funding round in 2022 and proximity to break-even while targeting 30% revenue growth.[2][3][4][6]
Qunomedical was founded by Dr. Sophie Chung in Berlin, Germany, with founding dates cited as 2015 or 2016 (formerly Junomedical).[1][2][3][4] Chung, as CEO, drew from a vision to revolutionize one-size-fits-all health systems by making high-quality treatments accessible regardless of patients' background or finances, addressing hurdles like opaque pricing, finding qualified doctors, and coordinating care—especially for medical travel.[3][7][8] The idea emerged from recognizing that patients often miss affordable global options due to complexity, leading to a platform with dedicated Patient Managers for 1-on-1 support.[7][8] Early traction built through vetting over 35 clinics and 1,000 physicians, evolving into Qunosuite for providers; pivotal growth included international partnerships and the 2022 €10m funding from DvH Ventures.[3][4][6]
Qunomedical rides the digital health transformation trend, digitizing fragmented global healthcare amid rising medical tourism, telemedicine demand, and post-pandemic efficiency needs.[2][4][8] Timing aligns with Europe's health tech boom—Berlin's startup ecosystem and needs for cross-border care in 35+ countries—countering long waits and one-size-fits-all systems with AI-enhanced CRM and patient matching.[1][3][5] Market forces like cost pressures on providers and patient empowerment via transparency favor its model, influencing the ecosystem by enabling clinics to maximize outreach while humanizing care, similar to Docplanner but with stronger global vetting and B2B tools.[1][6]
Nearing break-even with 30% revenue growth ambitions, Qunomedical is poised to scale Qunosuite amid health tech consolidation, potentially expanding AI-driven personalization and partnerships.[2][4] Trends like regulatory tailwinds for digital health (e.g., EU data portability) and rising global patient mobility will shape its path, evolving influence from niche medical travel facilitator to comprehensive CRM leader—empowering more humane, accessible care worldwide, true to its patient-first founding mission.[2][3][8]
Qunomedical has raised $14.0M across 3 funding rounds. Most recently, it raised $10.0M Series A in November 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 1, 2022 | $10M Series A | — | Bascom Ventures, Entrepreneur First, MS&AD Ventures, OAK HC/FT, Saga, Shasta Ventures, SNR, Abakar Saidov, Gordon Wintrob, Immad Akhund, Jonathan Siegel, Oleg Rogynskyy, Sean Harper, Zachary Sims, Bertelsmann, Calm/Storm Ventures, Dieter VON Holtzbrinck Ventures | Announced |
| Aug 15, 2017 | $2M Venture Round | — | 500 Startups, Kima Ventures, Anton Waitz | Announced |
| Aug 1, 2017 | $2M Seed | — | Project A Ventures, 500 Startups, Kima Ventures | Announced |
Qunomedical has raised $14.0M in total across 3 funding rounds.
Qunomedical's investors include Bascom Ventures, Entrepreneur First, MS&AD Ventures, Oak HC/FT, Saga, Shasta Ventures, SNR, Abakar Saidov, Gordon Wintrob, Immad Akhund, Jonathan Siegel, Oleg Rogynskyy.